Navigation Links
Cephalon Quarterly Conference Call Invitation
Date:1/12/2009

Fourth Quarter & Full Year 2008 Earnings Conference Call

Thursday, February 12, 2009, 5:00 p.m. U.S. EST

FRAZER, Pa., Jan. 12 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) has scheduled its regular quarterly earnings conference call covering fourth quarter and full year 2008 results for 5:00 p.m. EST on Thursday, February 12, 2009.

February 12, 2009 Schedule

4:10 p.m. EST Q4 & FY 2008 results will be distributed by PRNewswire

4:50 p.m. EST To participate in the conference call, dial 913-661-9178 and refer to Conference Code Number 9540364

5:00 p.m. EST Conference call begins promptly.

Simultaneous Webcast

Investors can listen to the call live by logging on to the company's website at www.cephalon.com and clicking on "Investor Information," then "Webcast." Please click on the link and follow the prompts for registration and access.

If you are unable to listen to the live broadcast, an audio or webcast replay of the call will be available approximately two hours after the event until Midnight EST, February 19, 2009. To listen to the audio replay, dial 1- 719-457-0820 and use the Conference Code Number 9540364.

Additional information presented on the conference call may be made available on the Investor Information page of the company's website.


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference
2. Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication
3. Video: Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkins Lymphoma
4. Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkins Lymphoma
5. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
6. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
7. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
8. Cephalon Conference Call Invitation
9. Cephalon Reports Strong First Quarter Earnings
10. Cephalon Appoints Gerald J. Pappert as General Counsel
11. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Overland Park, KS (PRWEB) , ... May 24, ... ... Kansas, announces an expansion of its services to provide one resource, from start ... print reviews and preparation, Life Safety Statement of Condition surveys requested by the ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... is pleased to welcome new Partner Firm Austin & Co., Inc. Headquartered ... to insurance, employee benefits, HR consulting, benefits technology, and beyond. As an ...
(Date:5/24/2016)... , ... May 24, 2016 , ... How to Write ... Raleigh, NC, http://www.fdanews.com/humanerrordrugdevice , Human error is known to be the major ... human error will ever be totally eliminated, many human performance problems can be prevented. ...
(Date:5/24/2016)... ... (PRWEB) May 24, 2016 ... members of its Advisory Board. Joining the Grow Healthy Advisory ... three of them embody the mission of our organization and bring ... to have them as we continue to expand our footprint as ...
(Date:5/24/2016)... ... 2016 , ... Backed by decades of experience, Metroloji Okulu ... the best suited solution to meet regulatory requirements. Their professional staff also performs ... Istanbul. , Metroloji Okulu specializes in MadgeTech’s line of medical and pharmaceutical ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... Open Access Journal Focusing ... Elsevier , a world-leading provider of scientific, ... the launch of Clinical Neurophysiology ... on clinical practice issues in clinical neurophysiology. The journal ... values and didactic reviews. It is an official journal ...
(Date:5/23/2016)... May 23, 2016 Global Paclitaxel ... pages, profiles 12 companies and the Paclitaxel analysis in ... on the industry and its players. This ... in nature, details the current state of the industry ... definitions, classifications, applications and industry chain structure. The Paclitaxel ...
(Date:5/23/2016)... Clarifying Vision - Prospects and Developments in ... What can be expected from the Ophthalmic ... the fastest rates? This visiongain report shows ... and prospects. ,Our 190-page report provides ... areas in the industry and the future market prospects. ...
Breaking Medicine Technology: